QL
NMRA icon

Quarry LP’s Neumora Therapeutics NMRA Stock Holding History

Quarry LP’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94 Buy
+55
New +$105 ﹤0.01% 2339
2025
Q1 		– Sell
-5,000
Closed -$53K – 1898
2024
Q4 		$53K Hold
5,000
– – 0.01% 724
2024
Q3 		$66K Sell
5,000
-5,000
-50% -$58.3K 0.02% 593
2024
Q2 		$98.3K Buy
+10,000
New +$103K 0.03% 352
2024
Q1 		– Sell
-50
Closed -$853 – 1829
2023
Q4 		$853 Buy
+50
New +$614 ﹤0.01% 1358

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quarry LP's NMRA Position: Q2 2026 in Review

Quarry LP opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 55 shares worth $94. The stake represents ﹤0.01% of the portfolio and ranks #2339 among its holdings. This is a return to the name: Quarry LP previously reported a position in NMRA as recently as Q4 2024.

Quarry LP first reported a position in NMRA in Q4 2023 and has held it in 5 quarters since. The position peaked at $98.3K in Q2 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Quarry LP held 55 shares of Neumora Therapeutics worth $94 as of Q2 2026.
  • Neumora Therapeutics was a new Quarry LP position in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2339 holding.
  • Quarry LP first reported a position in Neumora Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • Quarry LP's Neumora Therapeutics position peaked at $98.3K in Q2 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.